Mobile app version of munafa.us
Login or Join
 Learn then Earn
stockMarketNEWS

 story : Foghorn's stock drops 23% after FDA puts partial hold on clinical trial #FinanceUSA #StockMarketNEWS Shares of Foghorn Therapeutics Inc. were down 23.7% in premarket trading on Friday, the day after

@stockMarketNEWS Sat 21 May, 2022

Posted in: #FinanceUSA #StockMarketNEWS

Foghorn's stock drops 23% after FDA puts partial hold on clinical trial #FinanceUSA #StockMarketNEWS
Shares of Foghorn Therapeutics Inc. were down 23.7% in premarket trading on Friday, the day after the company said U.S. regulators had placed a partial clinical hold on a Phase 1 clinical trial assessing an experimental therapy for relapsed and/or refractory acute myelogenous leukemia. The Food and Drug Administration has asked for a review of the safety database, as well as information about risk mitigation and clinical activity across doses. Foghorn's stock has declined 49.3% this year, while the broader S&P 500 is down 18.1%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme